β¨ Health and Primary Industries Notices
NEW ZEALAND GAZETTE, No. 101 β 10 NOVEMBER 2016
Elanco Animal Health (a division of Eli Lilly and Company (NZ) Limited), Level 1, 123 Ormiston Road, Botany Junction, Auckland. Postal Address: 112 Wharf Road, West Ryde, New South Wales, Australia.
Dated at Wellington this 7th day of November 2016.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).
Concentration of active is greater than that approved for any similar product. This application is being publicly notified because the dose of active ingredient administered per kilogram liveweight is greater for this product than other dicyclanil-based products currently registered, resulting in a different risk profile.
2016-go6350
Revocation of Notices Under Section 24 of the Misuse of Drugs Act 1975
Pursuant to section 24(7) of the Misuse of Drugs Act 1975, I, John Crawshaw, acting under delegated authority from the Minister of Health, revoke the approval of the Capital and Coast Addiction Services and medical practitioner issued under this section on 7 March 2014 (New Zealand Gazette, 13 March 2014, No. 29, page 831).
Dated at Wellington this 6th day of November 2016.
DR JOHN CRAWSHAW, Director of Mental Health.
2016-go6359
Approval of Capital and Coast Addiction Services and Medical Practitioner to Provide Substitution Treatment Under Section 24 of the Misuse of Drugs Act 1975
Pursuant to section 24(7)(b) of the Misuse of Drugs Act 1975, I, John Crawshaw, acting under delegated authority from the Minister of Health, specify Capital and Coast Addiction Services as a service that may provide treatment with controlled drugs for people who are dependent on controlled drugs at the following place:
Wellington Regional Hospital
Administration Building
31 Mein Street
Newtown
Wellington 6021
And, pursuant to section 24(7)(a) of the Misuse of Drugs Act 1975, acting under delegated authority from the Minister of Health, I specify
Dr Sam McBride
as a medical practitioner, may:
a. prescribe, administer or supply controlled drugs for the treatment of dependence to controlled drugs as the lead clinician for Capital and Coast Addiction Services;
b. authorise in writing service/clinic medical practitioners as specified under subsection (2)(b) to:
i. prescribe, administer or supply controlled drugs for the treatment of dependence;
ii. authorise in writing general practitioners receiving clients from Capital and Coast Addiction Services as specified under subsection (2)(d); and
c. authorise in writing general practitioners receiving clients from Capital and Coast Addiction Services as specified under subsection (2)(d).
Conditions
-
Controlled drugs may only be prescribed, administered or supplied to people who are or have been clients of Capital and Coast Addiction Services.
-
This approval expires on 31 December 2017.
Dated at Wellington this 6th day of November 2016.
40
Next Page →
β¨ LLM interpretation of page content
πΎ
Notice of Application to Register a Trade Name Product
(continued from previous page)
πΎ Primary Industries & Resources7 November 2016
Agricultural Compounds, Veterinary Medicines, CLiK Extra Spray-On, MPI
- MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority)
π₯ Revocation of Notices Under Section 24 of the Misuse of Drugs Act 1975
π₯ Health & Social Welfare6 November 2016
Misuse of Drugs Act, Revocation, Capital and Coast Addiction Services
- John Crawshaw, Director of Mental Health
π₯ Approval of Capital and Coast Addiction Services and Medical Practitioner to Provide Substitution Treatment Under Section 24 of the Misuse of Drugs Act 1975
π₯ Health & Social Welfare6 November 2016
Misuse of Drugs Act, Substitution Treatment, Capital and Coast Addiction Services, Wellington
- Sam McBride (Doctor), Authorised to prescribe controlled drugs
- John Crawshaw, Director of Mental Health
NZ Gazette 2016, No 101